Lung Cancer
Improving Outcomes with Immuno-Oncology: Evolving Treatment Paradigms for First-Line ES-SCLC and Unresectable Stage III NSCLC
Friday, 20 November, 12:00-13:30 (SGT)
View the satellite invitation
Extending Longer-Term Survival in Lung Cancer and HNSCC with IO and Novel Combinations
Friday, 20 November, 12:00-13:30 (SGT)
View the satellite invitation
Improving Patient Outcomes in Early-Stage and Advanced EGFR-Mutant NSCLC: Emerging Strategies
Saturday, 21 November, 12:00-13:30 (SGT)
View the satellite invitation
Beyond 2020: Targeting EGFR Exon 19 and Exon 21 L858R in the New Era
Saturday, 21 November, 12:00-13:30 (SGT)
View the satellite invitation
Targeting the Undruggable in KRAS-mutated Advanced NSCLC and mCRC
Sunday, 22 November, 12:00-13:30 (SGT)
View the satellite invitation
Treatment Considerations for Advanced NSCLC: Now And In The Future
Sunday, 22 November, 12:00-13:30 (SGT)
View the satellite invitation
Getting Ahead in SCCHN: Dynamic Treatment Options with Cetuximab
Sunday, 22 November, 12:00-13:30 (SGT)
View the satellite invitation
Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.
View the complete ESMO Asia Virtual Congress 2020 Industry Sponsored Satellite Symposia Programme